STOCK TITAN

Iperionx Financials

IPX
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE June

This page shows Iperionx (IPX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Iperionx passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality
0.62x

For every $1 of reported earnings, Iperionx generates $0.62 in operating cash flow (-$21.8M OCF vs -$35.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
-$35.3M
YoY-61.8%

Iperionx reported -$35.3M in net income in fiscal year 2025. This represents a decrease of 61.8% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
-$38.8M
YoY-64.1%

Iperionx generated -$38.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 64.1% from the prior year.

Cash & Debt
$54.8M
YoY+65.3%

Iperionx held $54.8M in cash against $3.9M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
320M
YoY+24.4%

Iperionx had 320M shares outstanding in fiscal year 2025. This represents an increase of 24.4% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
-38.2%
YoY+4.3pp

Iperionx's ROE was -38.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.3 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$17.0M
YoY+238.0%

Iperionx invested $17.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 238.0% from the prior year.

IPX Income Statement

Metric Q2'26 Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

IPX Balance Sheet

Metric Q2'26 Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22
Total Assets $129.2M+23.0% $105.0M-9.3% $115.8M+108.9% $55.4M+62.8% $34.0M+49.3% $22.8M+26.7% $18.0M+81.6% $9.9M
Current Assets $69.6M+18.2% $58.9M-25.3% $78.8M+89.6% $41.5M+76.3% $23.6M+84.7% $12.8M+8.3% $11.8M+101.7% $5.8M
Cash & Equivalents $65.8M+20.1% $54.8M-28.9% $77.1M+132.6% $33.2M+91.3% $17.3M+45.2% $11.9M+4.4% $11.4M+101.6% $5.7M
Inventory $426K $0 $0-100.0% $17K N/A $0 N/A N/A
Accounts Receivable $1.2M+40.2% $823K-15.8% $977K-57.5% $2.3M-14.9% $2.7M+1084.3% $228K+170.4% $84K+274.8% $23K
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $21.0M+66.4% $12.6M+22.4% $10.3M+151.2% $4.1M+5.9% $3.9M+72.6% $2.2M-14.5% $2.6M+5.3% $2.5M
Current Liabilities $17.3M+104.9% $8.4M+26.3% $6.7M+118.7% $3.1M+16.2% $2.6M+59.4% $1.6M-10.1% $1.8M-11.9% $2.1M
Long-Term Debt $4.5M+13.3% $3.9M+9.4% $3.6M+250.6% $1.0M-15.9% $1.2M+114.8% $568K-25.4% $761K+101.3% $378K
Total Equity $108.2M+17.0% $92.4M-12.4% $105.5M+105.6% $51.3M+70.1% $30.2M+46.7% $20.6M+33.7% $15.4M+107.2% $7.4M
Retained Earnings -$144.0M-31.8% -$109.2M-21.2% -$90.1M-22.0% -$73.9M-17.8% -$62.7M-20.1% -$52.2M-20.0% -$43.5M-25.2% -$34.8M

IPX Cash Flow Statement

Metric Q2'26 Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

IPX Financial Ratios

Metric Q2'26 Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 4.03-3.0 6.99-4.8 11.80-1.8 13.62+4.6 8.97+1.2 7.74+1.3 6.43+3.6 2.81
Debt-to-Equity 0.040.0 0.040.0 0.03+0.0 0.02-0.0 0.04+0.0 0.03-0.0 0.050.0 0.05
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

No, Iperionx (IPX) reported a net income of -$35.3M in fiscal year 2025.

As of fiscal year 2025, Iperionx (IPX) had $54.8M in cash and equivalents against $3.9M in long-term debt.

Iperionx (IPX) has a return on equity of -38.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Iperionx (IPX) generated -$38.8M in free cash flow during fiscal year 2025. This represents a -64.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Iperionx (IPX) generated -$21.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Iperionx (IPX) had $105.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Iperionx (IPX) invested $17.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Iperionx (IPX) had 320M shares outstanding as of fiscal year 2025.

Iperionx (IPX) had a current ratio of 6.99 as of fiscal year 2025, which is generally considered healthy.

Iperionx (IPX) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Iperionx (IPX) had a return on assets of -33.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Iperionx (IPX) had $54.8M in cash against an annual operating cash burn of $21.8M. This gives an estimated cash runway of approximately 30 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Iperionx (IPX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Iperionx (IPX) has an earnings quality ratio of 0.62x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top